News

Pfizer recalls Chantix smoking cessation drug for increased cancer risk due to high levels of nitrosamine

Pfizer is voluntarily recalling lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the risk of cancer.